Semamax
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.
Molekulardaten
Reinheit
4113.58 g/mol
Molekulargewicht
SEM-2026-0267
Chargennummer
HPLC + Mass Spectrometry
Testmethode
Reinheit verifiziert
LaborgeprĂĽft
Modified GLP-1(7-37) analog with C-18 fatty acid chain
Forschungsstudien
Laborverifizierung
Zum Verifizieren scannen
Chargennummer: SEM-2026-0267
Reinheit: 99.3%
Wirkungsprofil
Wichtigste Vorteile
Kombinierbar mit
Diese Peptide werden häufig mit Semamax für verbesserte Ergebnisse kombiniert.
Verwandte Peptide
L-Carnitine
Injectable L-Carnitine
L-Carnitine is a naturally occurring compound that helps transport fatty acids into the mitochondria for energy production. Injectable forms bypass digestion, offering higher bioavailability and faster effects. Commonly used to support fat loss, energy, and athletic performance.
CJC-1295
CJC-1295 with DAC
CJC-1295 is a long-acting GHRH analog. It boosts natural growth hormone and IGF-1 levels by stimulating the pituitary. Modified with DAC for extended half-life and fewer injections. Often stacked with Ipamorelin for best results.
Bereit zum Entdecken Semamax?
Machen Sie unser geführtes Quiz, um Peptide zu finden, die zu Ihren Forschungszielen passen, oder durchsuchen Sie unseren vollständigen Katalog.